The9 Q2 EPS $0.01, Sales $712.000K
The9 (NASDAQ:NCTY) reported quarterly earnings of $0.01 per share. The company reported $712.000 thousand in sales this quarter.
Read original at benzingaStocks · News reference
The9 Says RF Acquisition Corp II Shareholders Approved Business Combination With Nanyang Biologics On August 19; Expects To Hold About 15% To 16% Of Combined Nasdaq-Listed Company
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 21, 2026, 12:31 PM
- Checked
- Aug 21, 2026, 12:31 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
The9 shares are trading higher. The company announced its investee Nanyang Biologics cleared a key step toward a planned Nasdaq listing after RF Acquisition shareholders approved their merger.
Read original at benzingaThe9 Says Investee Nanyang Biologics Received SEC Notice Of Effectiveness For Form F-4 Ahead Of Nasdaq Listing At $1.5B Pre-Transaction Valuation; Expects To Own 15% To 16% Of Combined Company
Read original at benzinga